After examining the RNA-Seq data of CRC patients from the TCGA database using the GEPIA website, we found that PRMT5 expression is in fact strongly positively correlated (p < 0.005, R = 0.81) with KRAS expression in CRC patient tumor samples (Figure 1). Here, PRMT5 is linked to colorectal carcinoma.